Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JOULE-MARS: Semaglutide and Behavioural Lifestyle Program in Adolescents With Obesity
NCT06852391Phase 4Recruiting
- Sponsor
- McMaster University
- Start
- Jun 2025
- Primary completion
- Dec 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in obesity, sponsored by McMaster University. Started Jun 2025; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06852391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06852391.